Evaluation of Self-Management Support Program for Elderly Patients with Lung Cancer Who Are Receiving Molecularly Targeted Therapy with Oral Agents : Pilot Study

Evaluation of Self-Management Support Program for Elderly Patients with Lung Cancer Who Are Receiving Molecularly Targeted Therapy with Oral Agents : Pilot Study - Evaluation of Self-Management Support Program for Elderly Patients with Lung Cancer Who Are Receiving Molecularly Targeted Therapy with Oral Agents : Pilot Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038812

Enrollment

Registered

2019-12-23

Start date

2019-12-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

The program aimed to develop and refine a self-management support program to maintain the QOL of elderly patients with lung cancer. The elements constituting the program are: 1) helping the patient m

In hospitalization for introduction of treatment or during outpatient visit within 2 weeks from start of treatment&quot

, second intervention as &quot

outpatient visit around 3-4 weeks after start of treatment&quot

, and third intervention as &quot

outpatient visit around 2 months after start of treatment&quot

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Lung cancer patients over 75 years old. Treatment with molecular target drugs will be started and will be continued in the outpatient department. Includes both cases of initial treatment or starting with regimen changes.

Exclusion criteria

Exclusion criteria: Patients with severe physical or mental symptoms. Difficult to communicate due to a decline in cognitive function.

Design outcomes

Primary

Measure	Time frame
QOL:SF-8(SF8 Health Survey)	—

Secondary

Measure	Time frame
Anxious/Depression : HADS(Hospital Anxiety and Depression Scale) Social support: Ask about the presence of "emotional support", "tool support", "information support" and "evaluative support. Symptoms: PRO-CTCAE(version 1.0)(Patient-Reported Outcome Common Terminology Criteria for Adverse Events)	—

Countries

Japan

Contacts

Public ContactAkiko Fukawa

Osaka Medical College Faculty of Nursing

fon163@osaka-med.ac.jp072-684-6217

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026